WF Holding Soars 80% After Crypto Pivot And China Expansion Plans - WF Holding (NASDAQ:WFF)

WF Holding (WFF) raised $18 million via a registered direct offering, selling 12 million shares at $1.50 each and issuing warrants. The company, a Malaysia-based FRP products manufacturer, conducted the offering under a Form F-3 registration. Proceeds will be used for general corporate purposes.

The Dow Jones rose 100 points, while the NASDAQ and S&P 500 saw mixed results. Goldman Sachs (GS) reported Q3 earnings of $17.01 per share, beating estimates. Several stocks saw significant price changes, including JBDI, BKYI, and FLYE. Commodities and European/Asian markets also showed varied movements.

TechnipFMC (FTI) signed a memorandum of understanding with BP to supply high-pressure subsea production systems for BP's future developments in the U.S. Gulf. FTI's stock rose 1.6% on the news. The agreement establishes a framework for future collaboration.

TD Cowen kept its Hold rating on Moderna (MRNA) with a $90 price target, implying a 62.8% downside from the Oct 20 close. The firm cited positive clinical developments and resilient revenue projections for Moderna's COVID-19 and INT franchises.

Roivant Sciences (ROIV) reported positive Phase III results for brepocitinib in treating uveitis, with over 60% of patients achieving steroid-free quiescence. The drug showed improvement in macular edema and visual function. Roivant plans to submit a supplemental new drug application in 2027 and will discuss commercial opportunities at an Investor Day.

TD Cowen reaffirmed a Buy rating on Incyte with a $140 price target, suggesting a 20.1% upside from the Oct 20 close. Jakafi sales grew 8% YoY to $2.59B in 2023, with peak U.S. sales projected to exceed $3B. Incyte's pipeline, including Opzelura, is expected to drive future revenue growth.